Kairos Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Kairos Pharma and other ETFs, options, and stocks.About KAPA
Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology.
CEOJohn S. Yu
CEOJohn S. Yu
Employees4
Employees4
HeadquartersLos Angeles, California
HeadquartersLos Angeles, California
Founded2013
Founded2013
Employees4
Employees4
KAPA Key Statistics
Market cap18.55M
Market cap18.55M
Price-Earnings ratio-2.79
Price-Earnings ratio-2.79
Dividend yield—
Dividend yield—
Average volume140.30K
Average volume140.30K
High today$0.8933
High today$0.8933
Low today$0.791
Low today$0.791
Open price$0.82
Open price$0.82
Volume62.18K
Volume62.18K
52 Week high$3.25
52 Week high$3.25
52 Week low$0.40
52 Week low$0.40
Stock Snapshot
The current Kairos Pharma(KAPA) stock price is $0.89, with a market capitalization of 18.55M. The stock trades at a price-to-earnings (P/E) ratio of -2.79.
On 2025-12-04, Kairos Pharma(KAPA) stock traded between a low of $0.79 and a high of $0.89. Shares are currently priced at $0.89, which is +12.6% above the low and -0.3% below the high.
The Kairos Pharma(KAPA)'s current trading volume is 62.18K, compared to an average daily volume of 140.3K.
During the past year, Kairos Pharma(KAPA) stock moved between $0.40 at its lowest and $3.25 at its peak.
During the past year, Kairos Pharma(KAPA) stock moved between $0.40 at its lowest and $3.25 at its peak.
People also own
Based on the portfolios of people who own KAPA. This list is generated using Robinhood data, and it’s not a recommendation.